Cellular and molecular bases of skeletal regeneration: What can we learn from genetic mouse models?

Bone

Volumn 64, Issue , 2014, Pages 211-221

  Abou Khalil, Rana ^a   Colnot, Céline ^a  

^a IMAGINE INSTITUTE   (France)

Author keywords

Conditional gene deletion; CRE Lox; Fracture repair; Knockout; Mice; Transgenesis

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; COLONY STIMULATING FACTOR; CRE RECOMBINASE; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; WNT PROTEIN;

ANGIOGENESIS; BONE CELL; BONE GROWTH; BONE REGENERATION; BONE REMODELING; CARTILAGE CELL; CELL COUNT; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; FRACTURE; FRACTURE HEALING; GENE DELETION; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETICALLY ENGINEERED MOUSE STRAIN; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOCLAST; OSTEOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TISSUE REPAIR; ANIMAL; ANIMAL MODEL; BONE; CYTOLOGY; GENETICS; INFLAMMATION; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

ANIMALS; BONE AND BONES; BONE REGENERATION; CELL LINEAGE; EXTRACELLULAR MATRIX; INFLAMMATION; MICE; MODELS, ANIMAL; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOCLASTS; SIGNAL TRANSDUCTION;

EID: 84899872746     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2014.03.046     Document Type: Review

References (214)

1. Einhorn T.A. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998, 46:S7-S21.
2. Ai-Aql Z.S., Alagl A.S., Graves D.T., Gerstenfeld L.C., Einhorn T.A. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 2008, 87:107-118.
3. Einhorn T.A., Majeska R.J., Rush E.B., Levine P.M., Horowitz M.C. The expression of cytokine activity by fracture callus. J Bone Miner Res 1995, 10:1272-1281.
4. Phillips A.M. Overview of the fracture healing cascade. Injury 2005, 36(Suppl. 3):S5-S7.
5. Tsiridis E., Upadhyay N., Giannoudis P. Molecular aspects of fracture healing: which are the important molecules?. Injury 2007, 38(Suppl. 1):S11-S25.
6. Dimitriou R., Tsiridis E., Giannoudis P.V. Current concepts of molecular aspects of bone healing. Injury 2005, 36:1392-1404.
7. Gerstenfeld L.C., Cullinane D.M., Barnes G.L., Graves D.T., Einhorn T.A. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 2003, 88:873-884.
8. Thompson Z., Miclau T., Hu D., Helms J.A. A model for intramembranous ossification during fracture healing. J Orthop Res 2002, 20:1091-1098.
9. Colnot C., Thompson Z., Miclau T., Werb Z., Helms J.A. Altered fracture repair in the absence of MMP9. Development 2003, 130:4123-4133.
10. Palomares K.T., Gleason R.E., Mason Z.D., Cullinane D.M., Einhorn T.A., Gerstenfeld L.C., Morgan E.F. Mechanical stimulation alters tissue differentiation and molecular expression during bone healing. J Orthop Res 2009, 27:1123-1132.
11. Lynch J.R., Taitsman L.A., Barei D.P., Nork S.E. Femoral nonunion: risk factors and treatment options. J Am Acad Orthop Surg 2008, 16:88-97.
12. Kamoun-Goldrat A., Le Merrer M. Animal models of osteogenesis imperfecta and related syndromes. J Bone Miner Metab 2007, 25:211-218.
13. Horton W.A., Hall J.G., Hecht J.T. Achondroplasia. Lancet 2007, 370:162-172.
14. Ferguson C., Alpern E., Miclau T., Helms J.A. Does adult fracture repair recapitulate embryonic skeletal formation?. Mech Dev 1999, 87:57-66.
15. Cullinane D.M., Salisbury K.T., Alkhiary Y., Eisenberg S., Gerstenfeld L., Einhorn T.A. Effects of the local mechanical environment on vertebrate tissue differentiation during repair: does repair recapitulate development?. J Exp Biol 2003, 206:2459-2471.
16. Vortkamp A., Pathi S., Peretti G.M., Caruso E.M., Zaleske D.J., Tabin C.J. Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair. Mech Dev 1998, 71:65-76.
17. Elefteriou F., Yang X. Genetic mouse models for bone studies-strengths and limitations. Bone 2011, 49:1242-1254.
18. Shwartz Y., Farkas Z., Stern T., Aszodi A., Zelzer E. Muscle contraction controls skeletal morphogenesis through regulation of chondrocyte convergent extension. Dev Biol 2012, 370:154-163.
19. Chen Y., Whetstone H.C., Lin A.C., Nadesan P., Wei Q., Poon R., Alman B.A. Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med 2007, 4:e249.
20. Day T.F., Guo X., Garrett-Beal L., Yang Y. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005, 8:739-750.
21. Gerstenfeld L.C., Cho T.J., Kon T., Aizawa T., Cruceta J., Graves B.D., Einhorn T.A. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs 2001, 169:285-294.
22. Gerstenfeld L.C., Cho T.J., Kon T., Aizawa T., Tsay A., Fitch J., Barnes G.L., Graves D.T., Einhorn T.A. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. J Bone Miner Res 2003, 18:1584-1592.
23. Zhang X., Schwarz E.M., Young D.A., Puzas J.E., Rosier R.N., O'Keefe R.J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002, 109:1405-1415.
24. Tsuji K., Bandyopadhyay A., Harfe B.D., Cox K., Kakar S., Gerstenfeld L., Einhorn T., Tabin C.J., Rosen V. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 2006, 38:1424-1429.
25. Soung do Y., Talebian L., Matheny C.J., Guzzo R., Speck M.E., Lieberman J.R., Speck N.A., Drissi H. Runx1 dose-dependently regulates endochondral ossification during skeletal development and fracture healing. J Bone Miner Res 2012, 27:1585-1597.
26. Cancedda R., Giannoni P., Mastrogiacomo M. A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 2007, 28:4240-4250.
27. Einhorn T.A. Clinically applied models of bone regeneration in tissue engineering research. Clin Orthop 1999, S59-S67.
28. Holstein J.H., Garcia P., Histing T., Kristen A., Scheuer C., Menger M.D., Pohlemann T. Advances in the establishment of defined mouse models for the study of fracture healing and bone regeneration. J Orthop Trauma 2009, 23:S31-S38.
29. Nunamaker D.M. Experimental models of fracture repair. Clin Orthop Relat Res 1998, S56-S65.
30. Hiltunen A., Vuorio E., Aro H.T. A standardized experimental fracture in the mouse tibia. J Orthop Res 1993, 11:305-312.
31. Manigrasso M.B., O'Connor J.P. Characterization of a closed femur fracture model in mice. J Orthop Trauma 2004, 18:687-695.
32. Oetgen M.E., Merrell G.A., Troiano N.W., Horowitz M.C., Kacena M.A. Development of a femoral non-union model in the mouse. Injury 2008, 39:1119-1126.
33. Colnot C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res 2009, 24:274-282.
34. Lutolf M.P., Weber F.E., Schmoekel H.G., Schense J.C., Kohler T., Muller R., Hubbell J.A. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 2003, 21:513-518.
35. Krause F., Younger A., Weber M. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. J Bone Joint Surg Am 2008, 90:1168. [author reply 1168-9].
36. Lieberman J.R., Daluiski A., Stevenson S., Wu L., McAllister P., Lee Y.P., Kabo J.M., Finerman G.A., Berk A.J., Witte O.N. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 1999, 81:905-917.
37. Barnes G.L., Kostenuik P.J., Gerstenfeld L.C., Einhorn T.A. Growth factor regulation of fracture repair. J Bone Miner Res 1999, 14:1805-1815.
38. Rosen V. Harnessing the parathyroid hormone, Wnt, and bone morphogenetic protein signaling cascades for successful bone tissue engineering. Tissue Eng Part B Rev 2011, 17:475-479.
39. Behonick D.J., Xing Z., Lieu S., Buckley J.M., Lotz J.C., Marcucio R.S., Werb Z., Miclau T., Colnot C. Role of matrix metalloproteinase 13 in both endochondral and intramembranous ossification during skeletal regeneration. PLoS One 2007, 2:e1150.
40. Xing Z., Lu C., Hu D., Yu Y.Y., Wang X., Colnot C., Nakamura M., Wu Y., Miclau T., Marcucio R.S. Multiple roles for CCR2 during fracture healing. Dis Model Mech 2010, 3:451-458.
41. Kos C.H. Cre/loxP system for generating tissue-specific knockout mouse models. Nutr Rev 2004, 62:243-246.
42. Koller B.H., Smithies O. Altering genes in animals by gene targeting. Annu Rev Immunol 1992, 10:705-730.
43. Stricklett P.K., Nelson R.D., Kohan D.E. Site-specific recombination using an epitope tagged bacteriophage P1 Cre recombinase. Gene 1998, 215:415-423.
44. Nagy A. Cre recombinase: the universal reagent for genome tailoring. Genesis 2000, 26:99-109.
45. Lewandoski M. Conditional control of gene expression in the mouse. Nat Rev Genet 2001, 2:743-755.
46. Orban P.C., Chui D., Marth J.D. Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci U S A 1992, 89:6861-6865.
47. Lobe C.G., Nagy A. Conditional genome alteration in mice. Bioessays 1998, 20:200-208.
48. Rajewsky K., Gu H., Kuhn R., Betz U.A., Muller W., Roes J., Schwenk F. Conditional gene targeting. J Clin Invest 1996, 98:600-603.
49. Albanese C., Hulit J., Sakamaki T., Pestell R.G. Recent advances in inducible expression in transgenic mice. Semin Cell Dev Biol 2002, 13:129-141.
50. Liu F., Woitge H.W., Braut A., Kronenberg M.S., Lichtler A.C., Mina M., Kream B.E. Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues. Int J Dev Biol 2004, 48:645-653.
51. Metzger D., Clifford J., Chiba H., Chambon P. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc Natl Acad Sci U S A 1995, 92:6991-6995.
52. Brocard J., Feil R., Chambon P., Metzger D. A chimeric Cre recombinase inducible by synthetic, but not by natural ligands of the glucocorticoid receptor. Nucleic Acids Res 1998, 26:4086-4090.
53. Feil R., Brocard J., Mascrez B., LeMeur M., Metzger D., Chambon P. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci U S A 1996, 93:10887-10890.
54. Feil R., Wagner J., Metzger D., Chambon P. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 1997, 237:752-757.
55. Kretzschmar K., Watt F.M. Lineage tracing. Cell 2012, 148:33-45.
56. Xie C., Xue M., Wang Q., Schwarz E.M., O'Keefe R.J., Zhang X. Tamoxifen-inducible CreER-mediated gene targeting in periosteum via bone-graft transplantation. J Bone Joint Surg Am 2008, 90(Suppl. 1):9-13.
57. Maes C., Kobayashi T., Selig M.K., Torrekens S., Roth S.I., Mackem S., Carmeliet G., Kronenberg H.M. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell 2010, 19:329-344.
58. Rodda S.J., McMahon A.P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 2006, 133:3231-3244.
59. Grcevic D., Pejda S., Matthews B.G., Repic D., Wang L., Li H., Kronenberg M.S., Jiang X., Maye P., Adams D.J., Rowe D.W., Aguila H.L., Kalajzic I. In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells 2012, 30:187-196.
60. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999, 21:70-71.
61. Novak A., Guo C., Yang W., Nagy A., Lobe C.G. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis 2000, 28:147-155.
62. Srinivas S., Watanabe T., Lin C.S., William C.M., Tanabe Y., Jessell T.M., Costantini F. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 2001, 1:4.
63. Buckwalter J.A., Hunziker E.B. Orthopaedics. Healing of bones, cartilages, tendons, and ligaments: a new era. Lancet 1996, 348(Suppl. 2):sII18.
64. Pape H.C., Marcucio R., Humphrey C., Colnot C., Knobe M., Harvey E.J. Trauma-induced inflammation and fracture healing. J Orthop Trauma 2010, 24:522-525.
65. Mountziaris P.M., Mikos A.G. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 2008, 14:179-186.
66. Kon T., Cho T.J., Aizawa T., Yamazaki M., Nooh N., Graves D., Gerstenfeld L.C., Einhorn T.A. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 2001, 16:1004-1014.
67. Yang X., Ricciardi B.F., Hernandez-Soria A., Shi Y., Pleshko Camacho N., Bostrom M.P. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 2007, 41:928-936.
68. Cho T.J., Kim J.A., Chung C.Y., Yoo W.J., Gerstenfeld L.C., Einhorn T.A., Choi I.H. Expression and role of interleukin-6 in distraction osteogenesis. Calcif Tissue Int 2007, 80:192-200.
69. Cho T.J., Gerstenfeld L.C., Einhorn T.A. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 2002, 17:513-520.
70. Iqbal J., Sun L., Kumar T.R., Blair H.C., Zaidi M. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci U S A 2006, 103:14925-14930.
71. Wang X., Yu Y.Y., Lieu S., Yang F., Lang J., Lu C., Werb Z., Hu D., Miclau T., Marcucio R., Colnot C. MMP9 regulates the cellular response to inflammation after skeletal injury. Bone 2013, 52:111-119.
72. Claes L., Recknagel S., Ignatius A. Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol 2012, 8:133-143.
73. Toben D., Schroeder I., El Khassawna T., Mehta M., Hoffmann J.E., Frisch J.T., Schell H., Lienau J., Serra A., Radbruch A., Duda G.N. Fracture healing is accelerated in the absence of the adaptive immune system. J Bone Miner Res 2011, 26:113-124.
74. Colburn N.T., Zaal K.J., Wang F., Tuan R.S. A role for gamma/delta T cells in a mouse model of fracture healing. Arthritis Rheum 2009, 60:1694-1703.
75. Alexander K.A., Chang M.K., Maylin E.R., Kohler T., Muller R., Wu A.C., Van Rooijen N., Sweet M.J., Hume D.A., Raggatt L.J., Pettit A.R. Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res 2011, 26:1517-1532.
76. Sasmono R.T., Oceandy D., Pollard J.W., Tong W., Pavli P., Wainwright B.J., Ostrowski M.C., Himes S.R., Hume D.A. A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 2003, 101:1155-1163.
77. Wang D., Gilbert J.R., Cray J.J., Kubala A.A., Shaw M.A., Billiar T.R., Cooper G.M. Accelerated calvarial healing in mice lacking Toll-like receptor 4. PLoS One 2012, 7:e46945.
78. Vuolteenaho K., Moilanen T., Moilanen E. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process. Basic Clin Pharmacol Toxicol 2008, 102:10-14.
79. Zhang M., Ho H.C., Sheu T.J., Breyer M.D., Flick L.M., Jonason J.H., Awad H.A., Schwarz E.M., O'Keefe R.J. EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair. J Bone Miner Res 2011, 26:792-802.
80. Gerstenfeld L.C., Thiede M., Seibert K., Mielke C., Phippard D., Svagr B., Cullinane D., Einhorn T.A. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2003, 21:670-675.
81. Simon A.M., Manigrasso M.B., O'Connor J.P. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002, 17:963-976.
82. Xie C., Liang B., Xue M., Lin A.S., Loiselle A., Schwarz E.M., Guldberg R.E., O'Keefe R.J., Zhang X. Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4. Am J Pathol 2009, 175:772-785.
83. Xie C., Ming X., Wang Q., Schwarz E.M., Guldberg R.E., O'Keefe R.J., Zhang X. COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healing. Bone 2008, 43:1075-1083.
84. Allen H.L., Wase A., Bear W.T. Indomethacin and aspirin: effect of nonsteroidal anti-inflammatory agents on the rate of fracture repair in the rat. Acta Orthop Scand 1980, 51:595-600.
85. Endo K., Sairyo K., Komatsubara S., Sasa T., Egawa H., Yonekura D., Adachi K., Ogawa T., Murakami R., Yasui N. Cyclooxygenase-2 inhibitor inhibits the fracture healing. J Physiol Anthropol Appl Human Sci 2002, 21:235-238.
86. Abdul-Hadi O., Parvizi J., Austin M.S., Viscusi E., Einhorn T. Nonsteroidal anti-inflammatory drugs in orthopaedics. J Bone Joint Surg Am 2009, 91:2020-2027.
87. Glass G.E., Chan J.K., Freidin A., Feldmann M., Horwood N.J., Nanchahal J. TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc Natl Acad Sci U S A 2011, 108:1585-1590.
88. Abou-Khalil R., Yang F., Mortreux M., Lieu S., Yu Y.Y., Wurmser M., Pereira C., Relaix F., Miclau T., Marcucio R.S., Colnot C. Delayed bone regeneration is linked to chronic inflammation in murine muscular dystrophy. J Bone Miner Res 2014, 29:304-315.
89. Partridge T. Pathophysiology of muscular dystrophy. Br J Hosp Med 1993, 49:26-36.
90. Ushiku C., Adams D.J., Jiang X., Wang L., Rowe D.W. Long bone fracture repair in mice harboring GFP reporters for cells within the osteoblastic lineage. J Orthop Res 2010, 28:1338-1347.
91. Kumagai K., Vasanji A., Drazba J.A., Butler R.S., Muschler G.F. Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res 2008, 26:165-175.
92. Otsuru S., Tamai K., Yamazaki T., Yoshikawa H., Kaneda Y. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 2008, 26:223-234.
93. Colnot C., Zhang X., Knothe Tate M.L. Current insights on the regenerative potential of the periosteum: molecular, cellular, and endogenous engineering approaches. J Orthop Res 2012, 30:1869-1878.
94. Zhang X., Xie C., Lin A.S., Ito H., Awad H., Lieberman J.R., Rubery P.T., Schwarz E.M., O'Keefe R.J., Guldberg R.E. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res 2005, 20:2124-2137.
95. Liu R., Birke O., Morse A., Peacock L., Mikulec K., Little D.G., Schindeler A. Myogenic progenitors contribute to open but not closed fracture repair. BMC Musculoskelet Disord 2011, 12:288.
96. Kawanami A., Matsushita T., Chan Y.Y., Murakami S. Mice expressing GFP and CreER in osteochondro progenitor cells in the periosteum. Biochem Biophys Res Commun 2009, 386:477-482.
97. Logan M., Martin J.F., Nagy A., Lobe C., Olson E.N., Tabin C.J. Expression of Cre recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis 2002, 33:77-80.
98. Park D., Spencer J.A., Koh B.I., Kobayashi T., Fujisaki J., Clemens T.L., Lin C.P., Kronenberg H.M., Scadden D.T. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell stem cell 2012, 10:259-272.
99. Lu C., Marcucio R., Miclau T. Assessing angiogenesis during fracture healing. Iowa Orthop J 2006, 26:17-26.
100. Medici D., Shore E.M., Lounev V.Y., Kaplan F.S., Kalluri R., Olsen B.R. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 2010, 16:1400-1406.
101. Leucht P., Kim J.B., Amasha R., James A.W., Girod S., Helms J.A. Embryonic origin and Hox status determine progenitor cell fate during adult bone regeneration. Development 2008, 135:2845-2854.
102. Deschaseaux F., Sensebe L., Heymann D. Mechanisms of bone repair and regeneration. Trends Mol Med 2009, 15:417-429.
103. Dishowitz M.I., Mutyaba P.L., Takacs J.D., Barr A.M., Engiles J.B., Ahn J., Hankenson K.D. Systemic inhibition of canonical Notch signaling results in sustained callus inflammation and alters multiple phases of fracture healing. PLoS One 2013, 8:e68726.
104. Garrison K.R., Donell S., Ryder J., Shemilt I., Mugford M., Harvey I., Song F. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. Health Technol Assess 2007, 11:1-150. [iii-iv].
105. Zhang H., Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996, 122:2977-2986.
106. Whitman M. Smads and early developmental signaling by the TGFbeta superfamily. Genes Dev 1998, 12:2445-2462.
107. Kugimiya F., Ohba S., Nakamura K., Kawaguchi H., Chung U.I. Physiological role of bone morphogenetic proteins in osteogenesis. J Bone Miner Metab 2006, 24:95-99.
108. Mishina Y., Suzuki A., Ueno N., Behringer R.R. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 1995, 9:3027-3037.
109. Mishina Y., Hanks M.C., Miura S., Tallquist M.D., Behringer R.R. Generation of Bmpr/Alk3 conditional knockout mice. Genesis 2002, 32:69-72.
110. Gamer L.W., Tsuji K., Cox K., Capelo L.P., Lowery J., Beppu H., Rosen V. BMPR-II is dispensable for formation of the limb skeleton. Genesis 2011, 49:719-724.
111. Solloway M.J., Dudley A.T., Bikoff E.K., Lyons K.M., Hogan B.L., Robertson E.J. Mice lacking Bmp6 function. Dev Genet 1998, 22:321-339.
112. Tsuji K., Cox K., Bandyopadhyay A., Harfe B.D., Tabin C.J., Rosen V. BMP4 is dispensable for skeletogenesis and fracture-healing in the limb. J Bone Joint Surg Am 2008, 90(Suppl. 1):14-18.
113. Tsuji K., Cox K., Gamer L., Graf D., Economides A., Rosen V. Conditional deletion of BMP7 from the limb skeleton does not affect bone formation or fracture repair. J Orthop Res 2010, 28:384-389.
114. Wang Q., Huang C., Xue M., Zhang X. Expression of endogenous BMP-2 in periosteal progenitor cells is essential for bone healing. Bone 2011, 48:524-532.
115. Kamiya N., Kobayashi T., Mochida Y., Yu P.B., Yamauchi M., Kronenberg H.M., Mishina Y. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. J Bone Miner Res 2010, 25:200-210.
116. Secreto F.J., Hoeppner L.H., Westendorf J.J. Wnt signaling during fracture repair. Curr Osteoporos Rep 2009, 7:64-69.
117. Ling L., Nurcombe V., Cool S.M. Wnt signaling controls the fate of mesenchymal stem cells. Gene 2009, 433:1-7.
118. Komatsu D.E., Mary M.N., Schroeder R.J., Robling A.G., Turner C.H., Warden S.J. Modulation of Wnt signaling influences fracture repair. J Orthop Res 2010, 28:928-936.
119. Hoeppner L.H., Secreto F.J., Westendorf J.J. Wnt signaling as a therapeutic target for bone diseases. Expert Opin Ther Targets 2009, 13:485-496.
120. Murakami S., Noda M. Expression of Indian hedgehog during fracture healing in adult rat femora. Calcif Tissue Int 2000, 66:272-276.
121. Long F., Chung U.I., Ohba S., McMahon J., Kronenberg H.M., McMahon A.P. Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 2004, 131:1309-1318.
122. Long F., Zhang X.M., Karp S., Yang Y., McMahon A.P. Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. Development 2001, 128:5099-5108.
123. Emans P.J., Spaapen F., Surtel D.A., Reilly K.M., Cremers A., van Rhijn L.W., Bulstra S.K., Voncken J.W., Kuijer R. A novel in vivo model to study endochondral bone formation; HIF-1alpha activation and BMP expression. Bone 2007, 40:409-418.
124. Wang Q., Huang C., Zeng F., Xue M., Zhang X. Activation of the Hh pathway in periosteum-derived mesenchymal stem cells induces bone formation in vivo: implication for postnatal bone repair. Am J Pathol 2010, 177:3100-3111.
125. Potts J.T. Parathyroid hormone: past and present. J Endocrinol 2005, 187:311-325.
126. Ren Y., Liu B., Feng Y., Shu L., Cao X., Karaplis A., Goltzman D., Miao D. Endogenous PTH deficiency impairs fracture healing and impedes the fracture-healing efficacy of exogenous PTH(1-34). PLoS One 2011, 6:e23060.
127. Jilka R.L. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 2007, 40:1434-1446.
128. Jilka R.L., Weinstein R.S., Bellido T., Roberson P., Parfitt A.M., Manolagas S.C. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 1999, 104:439-446.
129. Bellido T., Ali A.A., Plotkin L.I., Fu Q., Gubrij I., Roberson P.K., Weinstein R.S., O'Brien C.A., Manolagas S.C., Jilka R.L. Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 2003, 278:50259-50272.
130. Calvi L.M., Sims N.A., Hunzelman J.L., Knight M.C., Giovannetti A., Saxton J.M., Kronenberg H.M., Baron R., Schipani E. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest 2001, 107:277-286.
131. Kim S.W., Pajevic P.D., Selig M., Barry K.J., Yang J.Y., Shin C.S., Baek W.Y., Kim J.E., Kronenberg H.M. Intermittent PTH administration converts quiescent lining cells to active osteoblasts. J Bone Miner Res 2012.
132. Kakar S., Einhorn T.A., Vora S., Miara L.J., Hon G., Wigner N.A., Toben D., Jacobsen K.A., Al-Sebaei M.O., Song M., Trackman P.C., Morgan E.F., Gerstenfeld L.C., Barnes G.L. Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J Bone Miner Res 2007, 22:1903-1912.
133. Ogita M., Rached M.T., Dworakowski E., Bilezikian J.P., Kousteni S. Differentiation and proliferation of periosteal osteoblast progenitors are differentially regulated by estrogens and intermittent parathyroid hormone administration. Endocrinology 2008, 149:5713-5723.
134. Jilka R.L., O'Brien C.A., Ali A.A., Roberson P.K., Weinstein R.S., Manolagas S.C. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone 2009, 44:275-286.
135. Bodine P.V., Seestaller-Wehr L., Kharode Y.P., Bex F.J., Komm B.S. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1. J Cell Physiol 2007, 210:352-357.
136. Guo J., Liu M., Yang D., Bouxsein M.L., Saito H., Galvin R.J., Kuhstoss S.A., Thomas C.C., Schipani E., Baron R., Bringhurst F.R., Kronenberg H.M. Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab 2010, 11:161-171.
137. Bornstein P., Sage E.H. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 2002, 14:608-616.
138. Alford A.I., Hankenson K.D. Matricellular proteins: extracellular modulators of bone development, remodeling, and regeneration. Bone 2006, 38:749-757.
139. Gentili C., Cancedda R. Cartilage and bone extracellular matrix. Curr Pharm Des 2009, 15:1334-1348.
140. Malaval L., Monfoulet L., Fabre T., Pothuaud L., Bareille R., Miraux S., Thiaudiere E., Raffard G., Franconi J.M., Lafage-Proust M.H., Aubin J.E., Vico L., Amedee J. Absence of bone sialoprotein (BSP) impairs cortical defect repair in mouse long bone. Bone 2009, 45:853-861.
141. Hu D., Lu C., Sapozhnikova A., Barnett M., Sparrey C., Miclau T., Marcucio R.S. Absence of beta3 integrin accelerates early skeletal repair. J Orthop Res 2010, 28:32-37.
142. Ekholm E., Hankenson K.D., Uusitalo H., Hiltunen A., Gardner H., Heino J., Penttinen R. Diminished callus size and cartilage synthesis in alpha 1 beta 1 integrin-deficient mice during bone fracture healing. Am J Pathol 2002, 160:1779-1785.
143. Merry K., Dodds R., Littlewood A., Gowen M. Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone. J Cell Sci 1993, 104(Pt 4):1013-1020.
144. Duvall C.L., Taylor W.R., Weiss D., Wojtowicz A.M., Guldberg R.E. Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice. J Bone Miner Res 2007, 22:286-297.
145. Monfoulet L., Malaval L., Aubin J.E., Rittling S.R., Gadeau A.P., Fricain J.C., Chassande O. Bone sialoprotein, but not osteopontin, deficiency impairs the mineralization of regenerating bone during cortical defect healing. Bone 2010, 46:447-452.
146. Mackie E.J., Tucker R.P. The tenascin-C knockout revisited. J Cell Sci 1999, 112(Pt 22):3847-3853.
147. Taylor D.K., Meganck J.A., Terkhorn S., Rajani R., Naik A., O'Keefe R.J., Goldstein S.A., Hankenson K.D. Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing. J Bone Miner Res 2009, 24:1043-1054.
148. Lieu S., Hansen E., Dedini R., Behonick D., Werb Z., Miclau T., Marcucio R., Colnot C. Impaired remodeling phase of fracture repair in the absence of matrix metalloproteinase-2. Dis Model Mech 2011, 4:203-211.
149. Kosaki N., Takaishi H., Kamekura S., Kimura T., Okada Y., Minqi L., Amizuka N., Chung U.I., Nakamura K., Kawaguchi H., Toyama Y., D'Armiento J. Impaired bone fracture healing in matrix metalloproteinase-13 deficient mice. Biochem Biophys Res Commun 2007, 354:846-851.
150. Ash P., Loutit J.F., Townsend K.M. Osteoclasts derived from haematopoietic stem cells. Nature 1980, 283:669-670.
151. Arai F., Miyamoto T., Ohneda O., Inada T., Sudo T., Brasel K., Miyata T., Anderson D.M., Suda T. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med 1999, 190:1741-1754.
152. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999, 20:345-357.
153. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., Nguyen H.Q., Wooden S., Bennett L., Boone T., Shimamoto G., DeRose M., Elliott R., Colombero A., Tan H.L., Trail G., Sullivan J., Davy E., Bucay N., Renshaw-Gegg L., Hughes T.M., Hill D., Pattison W., Campbell P., Boyle W.J., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997, 89:309-319.
154. Ikeda T., Utsuyama M., Hirokawa K. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. J Bone Miner Res 2001, 16:1416-1425.
155. Kishimoto K., Kitazawa R., Kurosaka M., Maeda S., Kitazawa S. Expression profile of genes related to osteoclastogenesis in mouse growth plate and articular cartilage. Histochem Cell Biol 2006, 125:593-602.
156. Ota N., Takaishi H., Kosaki N., Takito J., Yoda M., Tohmonda T., Kimura T., Okada Y., Yasuda H., Kawaguchi H., Matsumoto M., Chiba K., Ikegami H., Toyama Y. Accelerated cartilage resorption by chondroclasts during bone fracture healing in osteoprotegerin-deficient mice. Endocrinology 2009, 150:4823-4834.
157. Larsson S., Fazzalari N.L. Anti-osteoporosis therapy and fracture healing. Arch Orthop Trauma Surg 2014, 134:291-297.
158. Sen M.K., Miclau T. Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions?. Injury 2007, 38(Suppl. 1):S75-S80.
159. Lu C., Miclau T., Hu D., Marcucio R.S. Ischemia leads to delayed union during fracture healing: a mouse model. J Orthop Res 2007, 25:51-61.
160. Schipani E., Maes C., Carmeliet G., Semenza G.L. Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF. J Bone Miner Res 2009, 24:1347-1353.
161. Das A., Botchwey E. Evaluation of angiogenesis and osteogenesis. Tissue Eng Part B Rev 2011, 17:403-414.
162. Pacicca D.M., Patel N., Lee C., Salisbury K., Lehmann W., Carvalho R., Gerstenfeld L.C., Einhorn T.A. Expression of angiogenic factors during distraction osteogenesis. Bone 2003, 33:889-898.
163. Yeh L.C., Lee J.C. Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells. Mol Cell Endocrinol 1999, 153:113-124.
164. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180.
165. Maes C., Goossens S., Bartunkova S., Drogat B., Coenegrachts L., Stockmans I., Moermans K., Nyabi O., Haigh K., Naessens M., Haenebalcke L., Tuckermann J.P., Tjwa M., Carmeliet P., Mandic V., David J.P., Behrens A., Nagy A., Carmeliet G., Haigh J.J. Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bones. EMBO J 2010, 29:424-441.
166. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999, 5:623-628.
167. Maes C., Coenegrachts L., Stockmans I., Daci E., Luttun A., Petryk A., Gopalakrishnan R., Moermans K., Smets N., Verfaillie C.M., Carmeliet P., Bouillon R., Carmeliet G. Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. J Clin Invest 2006, 116:1230-1242.
168. Carvalho R.S., Einhorn T.A., Lehmann W., Edgar C., Al-Yamani A., Apazidis A., Pacicca D., Clemens T.L., Gerstenfeld L.C. The role of angiogenesis in a murine tibial model of distraction osteogenesis. Bone 2004, 34:849-861.
169. Wan C., Gilbert S.R., Wang Y., Cao X., Shen X., Ramaswamy G., Jacobsen K.A., Alaql Z.S., Eberhardt A.W., Gerstenfeld L.C., Einhorn T.A., Deng L., Clemens T.L. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci U S A 2008, 105:686-691.
170. Vu T.H., Shipley J.M., Bergers G., Berger J.E., Helms J.A., Hanahan D., Shapiro S.D., Senior R.M., Werb Z. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998, 93:411-422.
171. Ortega N., Wang K., Ferrara N., Werb Z., Vu T.H. Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation. Dis Model Mech 2010, 3:224-235.
172. Street J., Bao M., de Guzman L., Bunting S., Peale F.V., Ferrara N., Steinmetz H., Hoeffel J., Cleland J.L., Daugherty A., van Bruggen N., Redmond H.P., Carano R.A., Filvaroff E.H. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 2002, 99:9656-9661.
173. Lu C., Hansen E., Sapozhnikova A., Hu D., Miclau T., Marcucio R.S. Effect of age on vascularization during fracture repair. J Orthop Res 2008, 26:1384-1389.
174. Lu C., Xing Z., Wang X., Mao J., Marcucio R.S., Miclau T. Anti-inflammatory treatment increases angiogenesis during early fracture healing. Arch Orthop Trauma Surg 2012, 132:1205-1213.
175. Kanczler J.M., Oreffo R.O. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 2008, 15:100-114.
176. Mountziaris P.M., Spicer P.P., Kasper F.K., Mikos A.G. Harnessing and modulating inflammation in strategies for bone regeneration. Tissue Eng Part B Rev 2011, 17:393-402.
177. Kobayashi T., Onodera S., Kondo E., Tohyama H., Fujiki H., Yokoyama A., Yasuda K. Impaired fracture healing in macrophage migration inhibitory factor-deficient mice. Osteoporos Int 2011, 22:1955-1965.
178. Tajima K., Takaishi H., Takito J., Tohmonda T., Yoda M., Ota N., Kosaki N., Matsumoto M., Ikegami H., Nakamura T., Kimura T., Okada Y., Horiuchi K., Chiba K., Toyama Y. Inhibition of STAT1 accelerates bone fracture healing. J Orthop Res 2010, 28:937-941.
179. Komatsu D.E., Bosch-Marce M., Semenza G.L., Hadjiargyrou M. Enhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1alpha deficiency. J Bone Miner Res 2007, 22:366-374.
180. Behr B., Leucht P., Longaker M.T., Quarto N. Fgf-9 is required for angiogenesis and osteogenesis in long bone repair. Proc Natl Acad Sci U S A 2010, 107:11853-11858.
181. Granero-Molto F., Myers T.J., Weis J.A., Longobardi L., Li T., Yan Y., Case N., Rubin J., Spagnoli A. Mesenchymal stem cells expressing insulin-like growth factor-I (MSCIGF) promote fracture healing and restore new bone formation in Irs1 knockout mice: analyses of MSCIGF autocrine and paracrine regenerative effects. Stem Cells 2011, 29:1537-1548.
182. Isefuku S., Joyner C.J., Reed A.A., Simpson A.H. Distraction osteogenesis in the Cbfa-1+/- mouse. J Orthop Res 2004, 22:1276-1282.
183. Wang Y.H., Qiu Y., Han X.D., Xiong J., Chen Y.X., Shi H.F., Karaplis A. Haploinsufficiency of endogenous parathyroid hormone-related peptide impairs bone fracture healing. Clin Exp Pharmacol Physiol 2013, 40:715-723.
184. Kawakatsu M., Kanno S., Gui T., Gai Z., Itoh S., Tanishima H., Oikawa K., Muragaki Y. Loss of Smad3 gives rise to poor soft callus formation and accelerates early fracture healing. Exp Mol Pathol 2011, 90:107-115.
185. Kellum E., Starr H., Arounleut P., Immel D., Fulzele S., Wenger K., Hamrick M.W. Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume. Bone 2009, 44:17-23.
186. Minear S., Leucht P., Jiang J., Liu B., Zeng A., Fuerer C., Nusse R., Helms J.A. Wnt proteins promote bone regeneration. Sci Transl Med 2010, 2. 29ra30.
187. Heilmann A., Schinke T., Bindl R., Wehner T., Rapp A., Haffner-Luntzer M., Nemitz C., Liedert A., Amling M., Ignatius A. The Wnt serpentine receptor Frizzled-9 regulates new bone formation in fracture healing. PLoS One 2013, 8:e84232.
188. Rundle C.H., Wang X., Wergedal J.E., Mohan S., Lau K.H. Fracture healing in mice deficient in plasminogen activator inhibitor-1. Calcif Tissue Int 2008, 83:276-284.
189. Matsushita Y., Sakamoto K., Tamamura Y., Shibata Y., Minamizato T., Kihara T., Ito M., Katsube K., Hiraoka S., Koseki H., Harada K., Yamaguchi A. CCN3 protein participates in bone regeneration as an inhibitory factor. J Biol Chem 2013, 288:19973-19985.
190. Bertrand J., Stange R., Hidding H., Echtermeyer F., Nalesso G., Godmann L., Timmen M., Bruckner P., Dell'Accio F., Raschke M.J., Pap T., Dreier R. Syndecan 4 supports bone fracture repair, but not fetal skeletal development, in mice. Arthritis Rheum 2013, 65:743-752.
191. Ishii M., Egen J.G., Klauschen F., Meier-Schellersheim M., Saeki Y., Vacher J., Proia R.L., Germain R.N. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 2009, 458:524-528.
192. Chiu W.S., McManus J.F., Notini A.J., Cassady A.I., Zajac J.D., Davey R.A. Transgenic mice that express Cre recombinase in osteoclasts. Genesis 2004, 39:178-185.
193. Yang C., McCoy K., Davis J.L., Schmidt-Supprian M., Sasaki Y., Faccio R., Novack D.V. NIK stabilization in osteoclasts results in osteoporosis and enhanced inflammatory osteolysis. PLoS One 2010, 5:e15383.
194. Murao H., Yamamoto K., Matsuda S., Akiyama H. Periosteal cells are a major source of soft callus in bone fracture. J Bone Miner Metab 2013, 31:390-398.
195. Akiyama H., Kim J.E., Nakashima K., Balmes G., Iwai N., Deng J.M., Zhang Z., Martin J.F., Behringer R.R., Nakamura T., de Crombrugghe B. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci U S A 2005, 102:14665-14670.
196. Ovchinnikov D.A., Deng J.M., Ogunrinu G., Behringer R.R. Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice. Genesis 2000, 26:145-146.
197. Hilton M.J., Tu X., Long F. Tamoxifen-inducible gene deletion reveals a distinct cell type associated with trabecular bone, and direct regulation of PTHrP expression and chondrocyte morphology by Ihh in growth region cartilage. Dev Biol 2007, 308:93-105.
198. Chen M., Lichtler A.C., Sheu T.J., Xie C., Zhang X., O'Keefe R.J., Chen D. Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase. Genesis 2007, 45:44-50.
199. Henry S.P., Jang C.W., Deng J.M., Zhang Z., Behringer R.R., de Crombrugghe B. Generation of aggrecan-CreERT2 knockin mice for inducible Cre activity in adult cartilage. Genesis 2009, 47:805-814.
200. Hyde G., Dover S., Aszodi A., Wallis G.A., Boot-Handford R.P. Lineage tracing using matrilin-1 gene expression reveals that articular chondrocytes exist as the joint interzone forms. Dev Biol 2007, 304:825-833.
201. Rountree R.B., Schoor M., Chen H., Marks M.E., Harley V., Mishina Y., Kingsley D.M. BMP receptor signaling is required for postnatal maintenance of articular cartilage. PLoS Biol 2004, 2:e355.
202. Yang G., Cui F., Hou N., Cheng X., Zhang J., Wang Y., Jiang N., Gao X., Yang X. Transgenic mice that express Cre recombinase in hypertrophic chondrocytes. Genesis 2005, 42:33-36.
203. Zhang M., Xuan S., Bouxsein M.L., von Stechow D., Akeno N., Faugere M.C., Malluche H., Zhao G., Rosen C.J., Efstratiadis A., Clemens T.L. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 2002, 277:44005-44012.
204. Lu Y., Xie Y., Zhang S., Dusevich V., Bonewald L.F., Feng J.Q. DMP1-targeted Cre expression in odontoblasts and osteocytes. J Dent Res 2007, 86:320-325.
205. Su N., Xu X., Li C., He Q., Zhao L., Chen S., Luo F., Yi L., Du X., Huang H., Deng C., Chen L. Generation of Fgfr3 conditional knockout mice. Int J Biol Sci 2010, 6:327-332.
206. Kolanczyk M., Kuhnisch J., Kossler N., Osswald M., Stumpp S., Thurisch B., Kornak U., Mundlos S. Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin. BMC Med 2008, 6:21.
207. Iwata K., Li J., Follet H., Phipps R.J., Burr D.B. Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia. Bone 2006, 39:1053-1058.
208. Loiselle A.E., Paul E.M., Lewis G.S., Donahue H.J. Osteoblast and osteocyte-specific loss of Connexin43 results in delayed bone formation and healing during murine fracture healing. J Orthop Res 2013, 31:147-154.
209. Yamaguchi T., Takada Y., Maruyama K., Shimoda K., Arai Y., Nango N., Kosaki N., Takaishi H., Toyama Y., Matsuo K. Fra-1/AP-1 impairs inflammatory responses and chondrogenesis in fracture healing. J Bone Miner Res 2009, 24:2056-2065.
210. Marsell R., Jonsson K.B., Cho T.J., Einhorn T.A., Ohlsson C., Schipani E. Mice expressing a constitutively active PTH/PTHrP receptor in osteoblasts show reduced callus size but normal callus morphology during fracture healing. Acta Orthop 2007, 78:39-45.
211. Huang Y., Zhang X., Du K., Yang F., Shi Y., Huang J., Tang T., Chen D., Dai K. Inhibition of beta-catenin signaling in chondrocytes induces delayed fracture healing in mice. J Orthop Res 2012, 30:304-310.
212. Arthur A., Panagopoulos R.A., Cooper L., Menicanin D., Parkinson I.H., Codrington J.D., Vandyke K., Zannettino A.C., Koblar S.A., Sims N.A., Matsuo K., Gronthos S. EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair. J Bone Miner Res 2013, 28:926-935.
213. Corral D.A., Amling M., Priemel M., Loyer E., Fuchs S., Ducy P., Baron R., Karsenty G. Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proc Natl Acad Sci U S A 1998, 95:13835-13840.
214. Yin D., Wang Z., Gao Q., Sundaresan R., Parrish C., Yang Q., Krebsbach P.H., Lichtler A.C., Rowe D.W., Hock J., Liu P. Determination of the fate and contribution of ex vivo expanded human bone marrow stem and progenitor cells for bone formation by 2.3ColGFP. Mol Ther 2009, 17:1967-1978.